Cargando…
A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood
BACKGROUND: Based on the hypothesis of a brain energy deficit, we investigated the safety and efficacy of triheptanoin on paroxysmal episodes in patients with alternating hemiplegia of childhood due to ATP1A3 mutations. METHODS: We conducted a randomized, double-blind, placebo-controlled crossover s...
Autores principales: | Hainque, Elodie, Caillet, Samantha, Leroy, Sandrine, Flamand-Roze, Constance, Adanyeguh, Isaac, Charbonnier-Beaupel, Fanny, Retail, Maryvonne, Le Toullec, Benjamin, Atencio, Mariana, Rivaud-Péchoux, Sophie, Brochard, Vanessa, Habarou, Florence, Ottolenghi, Chris, Cormier, Florence, Méneret, Aurélie, Ruiz, Marta, Doulazmi, Mohamed, Roubergue, Anne, Corvol, Jean-Christophe, Vidailhet, Marie, Mochel, Fanny, Roze, Emmanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5625655/ https://www.ncbi.nlm.nih.gov/pubmed/28969699 http://dx.doi.org/10.1186/s13023-017-0713-2 |
Ejemplares similares
-
Long-term follow-up in an open-label trial of triheptanoin in GLUT1 deficiency syndrome: a sustained dramatic effect
por: Hainque, Elodie, et al.
Publicado: (2019) -
Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency
por: Mochel, Fanny, et al.
Publicado: (2016) -
No effect of triheptanoin on exercise performance in McArdle disease
por: Madsen, Karen L., et al.
Publicado: (2019) -
Triheptanoin – Novel therapeutic approach for the ultra-rare disease mitochondrial malate dehydrogenase deficiency
por: Laemmle, Alexander, et al.
Publicado: (2021) -
Adult-onset Generalized Dystonia as the Main Manifestation of MEGDEL Syndrome
por: Giron, Camille, et al.
Publicado: (2018)